Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zaplatnikov (Moscow, Russian Federation), B. Blokhin (Moscow, Russian Federation), N. Geppe (Moscow, Russian Federation), E. Kondurina (Novosibirsk , Russian Federation), T. Voitovitch ( Minsk, Belarus), A. Sukalo (Minsk, Belarus). The results of a randomized clinical trial of the efficacy of the antibodies-based drug in influenza and acute respiratory viral infections in children. 1001

Member's Comments

No comment yet.

Related content which might interest you: Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009 Efficacy of recombinant human deoxyribonuclease (Rh-DNase) in infants hospitalised with respiratory syncytial virus bronchiolitis: a multicentre randomised double-blind clinical trial Source: Eur Respir J 2006; 28: Suppl. 50, 758s Year: 2006 The efficacy of antiviral therapy of acute respiratory infections in paediatric practice Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020 Year: 2020 High-dose inhaled corticosteroids prevent wheeze following respiratory syncytial virus infection: a randomized double-blind placebo-controlled trial Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008 A randomized, controlled, open-label study to evaluate the efficacy and safety of oral lopinavir-ritonavir in adults hospitalized with COVID-19 virus infection Source: Virtual Congress 2020 – Chinese programme 2020: Part I Year: 2020 Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial Source: Eur Respir J 2013; 42: 1064-1075 Year: 2013 Efficacy of immunotherapy with ribomunyl in children with recurrent respiratory infections: results of 3-year prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 338s Year: 2002 RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID Year: 2021 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patients Source: Annual Congress 2012 - Novel approaches to lung transplantation Year: 2012 Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Tele-assistance in chronic respiratory failure patients: a randomised clinical trial Source: Annual Congress 2008 - Integrated care and long-term strategies Year: 2008 Mechanistic model based meta-analysis for paediatric respiratory tract infection prophylaxis trial design Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Randomized controlled trial of chest physiotherapy in infants with viral acute bronchiolitis Source: International Congress 2017 – Assessing and targeting functional outcomes in respiratory physiotherapy Year: 2017 Palivizumab: Is it cost effective to extend the vaccination period for patients at risk of severe respiratory syncytial virus infection? Source: Virtual Congress 2021 – Acute and chronic lung infections in children Year: 2021 Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013 Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Pneumococcal vaccination in chronic respiratory patients – a cohort study Source: International Congress 2019 – Airway infection in COPD Year: 2019